Landscape Capital Management L.L.C. Has $5.61 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Landscape Capital Management L.L.C. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 11,089 shares of the healthcare conglomerate's stock after selling 578 shares during the quarter. UnitedHealth Group makes up 0.6% of Landscape Capital Management L.L.C.'s portfolio, making the stock its 17th biggest position. Landscape Capital Management L.L.C.'s holdings in UnitedHealth Group were worth $5,609,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $32,000. Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at about $40,000. Finally, DecisionPoint Financial LLC lifted its holdings in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock worth $52,000 after buying an additional 62 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded down $15.50 on Friday, hitting $524.94. The company had a trading volume of 9,914,705 shares, compared to its average volume of 4,261,985. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market cap of $480.17 billion, a PE ratio of 33.87, a PEG ratio of 1.37 and a beta of 0.62. The business has a 50-day simple moving average of $509.24 and a 200-day simple moving average of $542.37. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 EPS. The company's quarterly revenue was up 6.8% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is 54.19%.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the company. Oppenheimer raised their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Truist Financial cut their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a report on Monday, January 6th. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of "Buy" and a consensus price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.